METABOLIC MODULATION OF INTRATUMORAL CHOLESTEROL WITH ENGINEERED BACTERIA FOR THE TREATMENT OF CANCERS
Application
US20260077000A1
Kind: A1
Mar 19, 2026
Inventors
Hoi Leong Xavier WONG, Jiayan WU, Lixiang ZHAI, Pallavi ASTHANA
Abstract
A method of treating a cancer (e.g., a colorectal cancer, a liver cancer, a breast cancer, or a lung cancer) in a subject in need thereof by administering to the subject a therapeutically effective amount of (i) a bacterium that converts intestinal cholesterol to 4-cholesten-3-one (4-C-3) or (ii) 4-C-3. Also disclosed is a recombinant Escherichia coli TOP10 bacterium comprising a nucleic acid encoding cholesterol oxidase (CHOX), which is capable of converting cholesterol to 4-C-3 and can be used to treat gastrointestinal tract cancers including a colorectal cancer or lung cancer.
CPC Classifications
A61K 35/74
A61K 31/575
A61K 45/06
A61P 35/00
C07K 16/2863
C12N 9/0006
C12N 15/70
C12R 2001/19
C12Y 101/03006
Filing Date
2025-09-17
Application No.
19330914